top of page
Browse by category
Search
Liraglutide after RYGB results in significant weight loss and resolution of obesity-related conditions
Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...
Liraglutide after LABG does not significantly improve HbA1c or weight loss
The outcomes from a pilot randomised controlled trial have revealed that the addition of the GLP-1 agonist receptor liraglutide after...
Liraglutide improves associative learning in people with obesity
Researchers at the Max Planck Institute for Metabolism Research have measured how well the learning of associations works in participants...
Anti-obesity medications remain prohibitively expensive
Several anti-obesity medications could be manufactured and profitability sold worldwide at far lower estimated lower prices compared to...
Browse by tag
bottom of page